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CALIFORNIA'S PROPOSITION 37: WIL ITS FALURE
FORECAST THE FATE OF THE GM FOOD LABELING
MOVEMENT IN THE UNITED STATES ONCE AND FOR ALL?
MEREDITH K. ScHUH*
I. INTRODUCTION
The need for mandatory labeling on food products indicating the
presence of genetically modified organisms ("GMOs") is a controversial
debate in the field of agricultural biotechnology.' Proponents of genetically
modified ("GM") labeling argue, "[m]andatory labeling responds to
consumers' rights, offers greater choice, and provides more information on
food content." 2 In rebuttal, anti-labeling groups contend that providing a
label on GM food is unnecessary for several reasons, most importantly, the
lack of a "science-based justification for mandatory labeling of GM food
because there is no evidence that such foods pose any risks to human
health." 3 There is no substantial difference between bioengineered food and
other traditionally grown products.4 The Food and Drug Administration
("FDA") and the American Medical Association ("AMA") unequivocally
support this latter view.' If GM labeling is required, opponents assert
increased cost on producers and consumers would be significant.
Depending on the strictness of the labeling criterion, fear of litigation
exposure may leave manufacturers and retailers reluctant to supply GM
* Online Editor, KENTUCKY JOURNAL OF EQUINE, AGRICULTURE, & NATURAL RESOURCES
LAW, 2013-2014; B.A. 2011, University of Kentucky; J.D. expected May 2014, University of Kentucky.
1 Throughout this Note, "GMO" or "GM" will refer to genetically modified organisms, or
"genetically modified" or "modification," respectively. In particular, "GM" refers to "the human
alteration of the genotype of an organism, particularly food, through mutagenic techniques or
recombinant DNA ("rDNA") techniques." See Carl R. Galant, Labeling Limbo: Why Genetically
Modifed Foods Continue to Duck Mandatory Disclosure, 42 HOUS. L. REV. 125, 127 n.5 (2005) (citing
Statement of Policy: Foods Derived from New Plant Varieties, 57 Fed. Reg. 22984, 22991 (May 29,
1992) (refusing to mandate labeling)).
2 Collin A. Carter et al., Giannini Found. of Agric. Econ., California's Proposition 37:
Effects of Mandatory Labeling of GM Food, AGRIC. AND RESOURCE ECON. UPDATE, Sept.-Aug. 2012,
at 3, 3, available at http://giannini.ucop.edu/media/are-update/files/articlesNl5N6_2.pdf.
3 id.
U.S. FOOD & DRUG ADMIN., GUIDANCE FOR INDUSTRY: VOLUNTARY LABELING
INDICATING WHETHER FOODS HAVE OR HAVE NOT BEEN DEVELOPED USING BIOENGINEERING; DRAFT
GUIDANCE (2001), available at http://www.fda.gov/Food/GuidanceRegulation/
GuidanceDocumentsRegulatoryInformation/LabelingNutrition/ucm059098.htm [hereinafter DRAFT
GUIDANCE FOR INDUSTRY] (explaining that to the extent that there is a difference between traditional
and GM food products, the FDA does require labeling in an appropriate form).
s Id.; see also AMERICAN MEDICAL ASSOCIATION, REPORT 2 OF THE COUNCIL ON SCIENCE
AND PUBLIC HEALTH (A-12): LABELING OF BIOENGINEERED FOODS (RESOLUTIONS 508 AND 509-A-11)
7 (2012) [hereinafter AMA, REPORT 2], available at http://www.ama-assn.org/resources/doc/csaph/al2-
csaph2-bioengineeredfoods.pdf.
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products, which may affect the availability and price of remaining food
products on the market. 6
In recent years, state and local governments have attempted to pass
ballot initiatives requiring GM labeling in some form. However, despite
"strong consumer interest in mandatory labeling of bioengineered food,"8
significant legislation in the United States requiring GM labeling remains
unsuccessful. Ineffective lawmaking was subject to change in California
with the state's "Proposition 37" ("Prop 37") entitled "Mandatory Labeling
Genetically Engineered Food," which was introduced on the November 6,
2012 voting ballot as an "initiated state statute."9 However, supporters of
Prop 37 were disappointed when the initiative was defeated.'0 Although
Prop 37 failed, the GM labeling movement considered the media attention it
garnered a success in terms of GM awareness," and supporters vowed to
pursue the fight for consumer rights. Beyond trying to find success in state
legislatures, pro-labelers have petitioned courts with legal claims
concerning GM labeling; for example, legislation was initiated regarding
whether omitting a GM label constitutes false or deceptive advertising. In
response, anti-labelers suggest GM labels "will be interpreted as . . .
warning[s]" and "would imply a food safety risk that does not exist, and
this in itself would be misleading to consumers." 2
Before evaluating state regulation and the effect of Prop 37's
failure on the "Right to Know" food movement in the United States, this
Note will first provide a brief historical analysis of agricultural
biotechnology to explain the impact of mandatory GM labeling on the food
industry. Part II will discuss the policies of various federal agencies
regarding federal regulation of GM food products. In Part III, this Note will
examine case law to determine if the FDA could preempt state legislation
mandating GM labeling.' 3 Finally, in Part IV, the food labeling movement's
future in the U.S. will be explored with proposed suggestions regarding
compromise between consumers and the food industry on the labeling
6 See Carter et al., supra note 2.
See Valery Federici, Note, Genetically Modiied Food and Informed Consumer Choice:
Comparing U.S. andE U. Labeling Laws, 35 BROOK. J. INT'L L. 515, 536 & n.124 (2010) ("Despite the
lack of a federal labeling law, there is some form of labeling requirement under the laws of nine U.S.
states, and other states are debating laws.").
8 AMA, REPORT 2, supra note 5, at 7.
9 California Proposition 37, Mandatory Labeling of Genetically Engineered Food (2012),
BALLOTPEDIA,
http://ballotpedia.org/wikilindex.php/Califomia Proposition 37,_Mandatoty_LabelingofGenetically
Engineered Food (2012) (last visited Dec. 28, 2012) [hereinafter California Proposition 37].
I0d.
Mike Adams, Proposition 37 Appears to Have Failed in California, but GMO Labeling
Awareness Achieves Victory, INFOWARS.COM (Nov. 7, 2012), http://www.infowars.com/proposition-37-
appears-to-have-failed-in-califomia-but-gmo-labeling-awareness-achieves-victory/.
12 Carter et al., supra note 2.
"3 Part III will also include an in-depth discussion of California's Proposition 37 and the
effect of its failure on the GM food movement in the United States.
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issue. The solution to the problem involves educating the public in the field
of agricultural biotechnology, which will likely ease consumers' fear of the
unknown. 14 The AMA also provides valuable insights, which could pacify
those behind the "Right to Know" movement. While there are many
potential benefits and drawbacks to labeling, the failure of the United States
to develop labeling laws, may signal that there are legitimate reasons for
not enacting such laws.
II. A HISTORY OF GMOs: BIOTECHNOLOGY IN THE FIELD OF AGRICULTURE
Decades before Prop 37 was recommended, scientists made
important advances in the field of genetic modification, developing
"transgenic technology," which "involves the introduction of an
advantageous genetic trait into a plant or animal via the direct transfer of a
gene or other construct conferring expression of that trait."" The FDA
refers to food crops produced through transgenic technology as
"bioengineered," a term the AMA also adopts.' 6 In contrast, traditional
plant breeding is a "process by which scientists select particular plant
specimens with desirable traits 'from a great variety of naturally occurring
types of plants' and reproduce them by pollinating other plants with the
pollen carrying desirable traits." 7 At a rudimentary level, bioengineering
involves directly modifying an organism's genes, an inherently more
controversial procedure, while traditional crop production only indirectly
modifies an organism's genes.' 8
Direct gene modification reveals positive effects through
bioengineering, including "tolerance to herbicides, toxicity to certain pests,
resistance to viruses, increased yields, tolerance of extreme growing
conditions," and "increased vitamin content." 9 Although bioengineering
generates opposition, its benefits are undeniable. For example, using the
Bacillus thuringiensis gene ("Bt") allows farmers to produce Bt crops
without using "synthetic chemical pesticides," or by using extremely low
levels of the pesticides. 20 Other genes allow farmers to utilize "herbicide
glyphosate" more effectively, which is "preferable to chemical herbicide
alternatives used in conventional agriculture" due to low toxicity and safe
14 See Federici, supra note 7, at 522 ("This desire for labels is likely the result of the popular
fear of the unknown. People are often skeptical of the unfamiliar, so it is not surprising that most
consumers are against eating GM food. . . .").
15 See AMA, REPORT 2, supra note 5, at 1-2.
'
6 Id. at 2.
17 Federici, supra note 7, at 522-23.
" id. at 523.
19 Id.
20 Id. at 523-24.
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consumption for humans and animals. 2 1 As demonstrated, a significant
advantage derived from bioengineering is a decline in the use of chemical
pesticides. As a result, the environment and workers' health are better
protected and plant biodiversity is promoted.22 Furthermore, consumers
benefit because a reduction in the use of such pesticides leads to a reduction
of pesticide residue on produce available in grocery stores.23
Proponents of bioengineering technology contend that mandatory
GM labeling should be avoided because of these positive effects. If such
laws were implemented, it is probable manufacturers might "look for
alternative, and possibly inferior, non-GM substitute ingredients to avoid
labeling." 24 Unfortunately, likely alternatives to GM ingredients, such as
imported palm oil, are linked with possible "health problems.. .and
environmental concerns."2 5 Despite the potential negative effects of
mandatory labeling, proponents maintain "the potential human health
effects of consuming bioengineered food have not been fully explored," 2 6
justifying cautious resistance to GM technology. The AMA observes,
however, that in the past twenty years in which bioengineered foods have
been consumed, no harmful effects on human health "have been reported
and/or substantiated in the peer-reviewed literature."27 Nevertheless, "a
small potential" for harmful consequences still exists; particularly in
relation to horizontal gene transfer, allergenicity, and toxicity, which all
pose conceivable risks to human health.28
A. Potential GM Threats to Human Health
The AMA describes horizontal gene transfer ("HGT") as a "process
by which an organism transfers genetic material to another organism other
than its offspring and which is followed by integration and expression of
the genetic material." 29 The concern is that when humans ingest a
bioengineered food produced from a transgenic plant expressing antibiotic-
resistance markers ("ARMs"), "it is theoretically possible that the ARM
could be taken up and stably integrated into enteric bacteria" present in the
human mouth, "resulting in bacteria that are resistant to specific
antibiotics."30 That is, through the HGT process, consumers could ingest
21 Id. at 524 (explaining that herbicide glyphosate is a safer, better alternative to many other
herbicides and is currently marketed under the Roundup brand).
2 2 Id. at 525.
23 id
24 See Carter et al., supra note 2, at 4.
25 id
26 See AMA, REPORT 2, supra note 5, at 2.
27 id
28 id
29 Id. at 3.
30 id
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bioengineered food that decreases the ability to respond to antibiotics.
Although the integration described may be technically possible, such an
occurrence is unlikely and has never been reported. 3' Another fear involves
ingesting "foreign" DNA existing in the transgenes.32 This fear is also
unfounded. DNA breaks down during food processing, is exposed to
"degradation enzymes . . . when consumed," and lastly, is "subjected to
bacterial restriction enzymes that cleave foreign DNA." As a result of
these removal processes, the likelihood of stable integration of foreign
DNA through HGT is practically nonexistent.
Possible toxicity levels in protein products of transgenes alarm
consumers as well, 34 but the AMA indicates safety assessments performed
by producers "based on the concept of 'substantial equivalence"' should
eliminate concern for potential harm in this area.35 Producers compare "the
new transgenic crop with its conventionally bred counterpart that is
generally accepted as safe based on a history of human consumption."36 A
transgenic crop is substantially equivalent to its counterpart if it retains
"similar levels and variations of critical nutrients and toxicants," and thus,
is safe for human consumption.3 ' To the extent a transgenic crop is
materially different from its counterpart, it undergoes additional testing.
Perhaps the most significant threat to human health involving
bioengineered food products, however, relates to allergenicity problems.
Consumers are apprehensive a "transgene expressed by transgenic crops
has the potential to encode a protein that is allergenic to humans. "0 Two
documented cases reported a potential allergen concern, but due to "pre-and
post-market safety procedures," human exposure was avoided.4 0 The AMA
emphasizes the importance of thorough pre-market evaluation as the "most
effective tool to protect the public."4' Current safety procedures require
appraising each food product "based on a 'weight-of-evidence' approach"
in which various factors are considered to determine if concern regarding
potential allergenicity is warranted.4 2 These procedures have proven
successful, but "absolute avoidance of all risk is not achievable;" thus,
"research to examine more effective methods of allergenicity is ongoing.,43
While the AMA supports the use of agricultural biotechnology, it still
32 id
33 Id
34 Id at 4.35 id.
36 id.
37 id.
38 id
40id
4' Id at 5.
42 id.
43 id
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advocates for regular safety assessments and updated research on GMOs'
impact on human health and the environment."
B. Pro-Labelers v. Labeling Opponents: Who Has the Better Argument?
Notwithstanding the scientific evidence indicating human
consumption of bioengineered food is safe, anti-GM proponents strongly
protest transgenic technology, mainly out of concern over potential risks
associated with such products, or more aptly, a fear of the unknown.45
GMO opponents include: various religious sects, organic food cooperatives,
and certain environmental organizations including Greenpeace.4 6 These
opponents advocate for informed consumer choice, claiming a right to
know whether foods have been "tampered with" through bioengineering
production methods.4 7 Moreover, beyond human health effects,
environmental groups contend that "certain risks to the environment of gene
pollution and reduction of biodiversity are in fact already occurring and
significantly outweigh the benefits of GMOs."AE In the United States,
opposition to transgenic technology has materialized as a mandatory GM
labeling crusade, echoing the anti-GM attitude heralded overseas. Pro-
labelers argue if producers and manufacturers of food products were
required to disclose GM content, consumers could effectively make an
informed food choice and avoid any potential health risks associated with
GMOs. While this argument may carry weight on a personal and individual
level, science-based evidence suggests "'traditional breeding methods, not
genetic engineering"' have resulted in "'the only known cases of increased
or new harmful compounds.'4 9 One reason for this, as previously stated, is
genetic engineering reduces, and in some cases, eliminates the need for the
use of harmful chemical pesticides.
Conversely, anti-labelers rely heavily on the fact that transgenic
technology provides numerous benefits to consumers and agriculture in
general. Although biotechnology poses potential health risks, these
problems also exist in traditional plant breeding, perhaps to an even greater
degree. Additionally, mandatory labeling would entail serious costs, which
consumers would likely bear.50 The AMA estimates mandatory labeling
"would increase the average household's annual grocery bill by $140-200
per year.',5 1 Most importantly, GM proponents trust science-based evidence
SId. at 8.
45 Federici, supra note 7, at 526-27.
46 id.
47 Id. at 517, 527.
41 Id. at 527.
49 Id. ("Thus, as opponents of genetic modification through biotechnology do not oppose
traditional plant breeding, their arguments against biotechnology are specious.").
so AMA, REPORT 2, supra note 5, at 7.
5 1 Id.
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validated by the FDA and the AMA indicating that GM products are safe
for human consumption.
Anti-labelers have a more persuasive argument under current
federal regulations. While pro-labelers maintain the importance of
"informed choice" in food consumption, the U.S. government regards a
consumer's "right to know" what they are putting in their bodies as an
insufficient reason to require states to label GM products accordingly.
Currently, consumers are privy to material information regarding the
nutritional composition of food, but the FDA's definition of materiality
versus what is perceived as material by many consumers varies
considerably. Labeling proponents would answer questions regarding
"whether genetic modification of food is material to consumers in their
decisions to purchase and consume food" in the affirmative.52 However, the
FDA does not consider "public demand for disclosure of GM content"
material information for consumers. If there is no actual distinction
between a conventionally produced food item and a GM food product, then
the costs imposed by a mandatory labeling scheme weigh in favor of
pursuing alternative measures to achieve informed consumer choice in the
food industry.
III. FEDERAL REGULATION OF BIOENGINEERED FOOD PRODUCTS
As techniques in genetic plant and animal modification progress,
the FDA and other federal agencies intensify regulation. Currently,
approximately one dozen transgenic crops are "marketed for human
consumption," but more than eighty crops have "regulatory clearance in the
[United States]."54 The most commonly used crops include soybeans, corn,
sugar beets, and cotton; surprisingly, "approximately 70% of processed
foods sold in U.S. grocery stores contain ingredients derived" from these
commonly used GM crops. FDA regulations concerning food labeling are
delineated in the Federal Food and Drug Cosmetic Act ("FD&C Act")."
The FDA's scientific approach to nutritional labeling applies to "all food,
whether or not they are derived from transgenic crops or animals" and, "the
FDA has the authority to initiate regulatory action if a product fails to meet
the requirements for the FD&C Act."57
Two sections in the FD&C Act affect GM food product labeling.
First, Section 403(i) requires the food product to assume a "common or
usual name" or "an appropriately descriptive term;" otherwise, the food is
52 Federici, supra note 7, at 530.
54 AMA, REPORT 2, supra note 5, at 2.
ss Id.56 id. at 5.
57 id
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considered "misbranded," and therefore, the label is false or misleading.s A
GM food product only requires a name change if the transgenic food is
"significantly different" from its conventional counterpart. If the new GM
product is not significantly different from its traditional counterpart
because, for example, it does not differ in nutritional quality or taste, then a
name change is not appropriate and the FDA has no basis for regulatory
60
action.
Second, Section 201(n) requires food labels contain all material
information concerning the product.6 1 The FDA defines material facts as
"information about the attributes of the food itself."62 If a label fails to
disclose all material facts, it is considered misleading, and the FDA may
take regulatory action. The FDA concludes "the fact that a food or any of
its ingredients were produced using transgenic methods is not considered
material, and therefore does not constitute information that must be
disclosed in labeling."6 However, labels must reveal the presence of
allergens that "consumers would not expect to be present based on the name
of the food."" The FDA does permit voluntary labeling indicating
production methods, but such information cannot be false or misleading.65
In response to manufacturers' desire to provide advisory statements on
labels indicating the presence of GMOs in their products, the FDA provided
nonbinding recommendations in a 2001 policy report ensuring such
statements would not be misleading to the consuming public. The FDA
acknowledged the concern surrounding biotechnology, but it stated that,
unless the transgenic product is materially different from its traditional
counterpart or poses a new safety risk, the FDA "has neither a scientific nor
a legal basis to require such labeling" under Sections 403(a) or 201(b) of
the FD&C Act.
In addition to enforcing its labeling policies, the FDA utilizes pre-
and post-market evaluations to guarantee the safety of bioengineered
foods. Specifically, companies planning to market GM food products
approach the FDA, discuss "relevant safety issues," and submit a "safety
5 DRAFT GUIDANCE FOR INDUSTRY, supra note 4,% 4-5.
59 Id. 15.
60 AMA, REPORT 2, supra note 5, at 5.
61 DRAFT GUIDANCE FOR INDUSTRY, supra note 4,1 5.
62 AMA, REPORT 2, supra note 5, at 6.
63 id.
6 DRAFT GUIDANCE FOR INDUSTRY, supra note 4,15.
65 AMA, REPORT 2, supra note 5, at 6.
6 DRAFT GUIDANCE FOR INDUSTRY, supra note 4, % 8, 10 (providing guidance as to how
"informative statements on labels" can be made "without being misleading," including the example,
"[t]his product contains high oleic acid soybean oil from soybean developed using biotechnology to
decrease the amount of saturated fat.").
67 AMA, REPORT 2, supra note 5, at 5, 6.
6 Id at 6.
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assessment report containing test data on the food in question." 69 Currently,
consultation between the FDA and such companies is not mandatory but
very common considering "to date, all manufacturers.. .have engaged in the
voluntary notification process."7 0 The AMA recommends, however, "pre-
market safety assessment should shift . . . to a mandatory requirement,"
despite the fact that manufacturers intending to market new bioengineered
products already routinely follow the notification process.7' Aside from this
suggestion, the AMA fully supports the FDA's labeling policies and safety
measures, but it advises the agency to "remain alert to any new data on the
health consequences of bioengineered foods and update its regulatory
policies accordingly."72
Advocating on behalf of farmers and consumers, the United States
Department of Agriculture ("USDA") agrees that bioengineering is a
"precise and predictable method" utilized to improve the sustainability of
crops through the introduction of a variety of traits. Accordingly, the
USDA's Animal and Plant Health Inspection Service ("APHIS") "has
safely deregulated or approved more than 70 GE products."74 The
deregulation process is essential to producing GM products commercially,
but with the combined efforts of the APHIS, the FDA, and the EPA, the
USDA believes certified bioengineered food products can be developed
with no risk to human health or the nation's environment.75 Like the AMA,
the USDA stresses the importance of continued research in the field of
agricultural biotechnology to capitalize on its numerous potential benefits.
Significantly, the AMA's position on bioengineered food was rendered in
the spring of 2012, eleven years after the FDA's most recent guidance
report on the subject. In their report, the AMA confirms no new scientific
evidence has surfaced suggesting harmful health consequences from the
consumption of bioengineered foods, more than a decade after the FDA
declined to require special labeling regulations.
Despite scientific confirmation that mandatory labeling of GM food
products is unnecessary, support for the "Right to Know" food movement
continues to grow. In addition to local community collaboration, national
organizations, like the Center for Food Safety ("CFS"), strongly support
69 id.
70 id
71 Id. at 7.72 JId. at 8.
" U.S. DEP'T OF AGRIC., GENETICALLY ENGINEERED RICE (2006) [hereinafter GENETICALLY
ENGINEERED RICE], available at
http://www.usda.gov/wps/portallusdalusdahome?contentidonly-true&contentid=2006/08/0306.xml; see
also Federici, supra note 8, at 534 ("There is also a strong farmers' lobby in the United States that is
generally in favor of GM technology ... which has invested vast sums of money in the development of
these gene manipulation methods.").
74 id.
75id.
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labeling campaigns. The CFS condemns the United States for lagging
behind the E.U. and developed countries regarding the adoption of labeling
laws for bioengineered foods, arguing consumers must be provided the
"information they overwhelmingly believe to be important, for a host of
health, environmental, ethical and religious reasons."76 In 2011, the CFS
submitted a petition to the FDA, demanding mandatory labeling, and in
early 2012, the FDA responded, "it had not yet made a decision . . . and
would continue to consider" the request.7 7 Of course, this begs the question
of whether the FDA even has the authority to require mandatory labeling on
GM products, considering its position on transgenic production methods.
In Alliance for Bio-Integrity v. Shalala, the federal District Court
for the District of Columbia ruled the FD&C Act "grants the FDA limited
authority to require labeling of genetically modified foods."78 Essentially,
the court concluded, "[a]bsent risks to consumer health or uniform changes
to food derived through recombinant technology, the FDA is not authorized
to impose food labeling." 79 The court made this conclusion because the
FDA does not consider the production process of food items material
information that must be disclosed under its misbranding laws.s0 The court
explained it would be misleading to label a GM product as different from
its traditionally-produced counterpart if it does not materially vary, even
though consumers may "misperceiv[e] the product as different" due to the
presence of GMOs.8 ' The plaintiffs in Alliance asserted the FDA wrongly
interpreted the scope of the phrase material facts under the FD&C Act and,
further contended "widespread consumer interest" should have been given
greater weight in consideration of mandatory labeling regulations. 82
However, the court found consumer apprehension of the undetermined
potential health effects of biotechnology insufficient to require mandatory
labeling on GM products.83
In addition to federal agency regulations, members of the U.S.
Senate and House of Representatives have endorsed mandatory labeling at
the federal level, but these legislative attempts have failed.84 For example,
in 2008, a bill entitled the "Genetically Engineered Food Right to Know
76 About GE Food Labeling, CENTER FOR FOOD SAFETY, http://gefoodlabels.org/gmo-
labeling/ (last visited Sept. 29, 2013).
" AMA, REPORT 2, supra note 5, at 6.
78 Alliance for Bio-Integrity v. Shalala, 116 F. Supp. 2d 166, 178 (D.C. Cir. 2000)
(distinguished by K.V. Pharmaceutical Co. v. U.S. Food and Drug Administration, 889 F. Supp. 2d 119
(D.C. Cir. 2012)).
79 Alicia T. Simpson, Note, Buying and Eating in the Dark: Can the Food and Drug
Administration Require Mandatory Labeling of Genetically Engineered Foods? Alliance for Bio-
Integrity v. Shalala, et al., 116 F. Supp.2d 166 (2000), 19 TEMP. ENVTL. L. &TECH. J. 225, 228 (2001).
so Id. at 231.
" Id. at 230.
82 id.
83 Fde
'4 Federici, supra note 7, at 535.
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Act" was introduced in the House of Representatives that would modify
sections of the FD&C Act and require that foods containing GMOs or foods
produced with genetically modified material "be labeled with the text
'Genetically Engineered' or '[t]his product contains a genetically
engineered material."' 85 However, several exemptions were incorporated
into the bill, including exceptions for "food served in restaurants or retail
establishments," but the Act "would institute civil penalties and authorize
private suits for violations."8  Prior versions of this bill have "all died in
subcommittees," but the bill is reintroduced every year.87 Significantly,
provisions of this Act closely mirrored various portions of a state bill
proposed and defeated several years later: California's Prop 37.
IV. STATE REGULATION: CASE LAW AND CALIFORNIA'S PROPOSITION 37
A. Legislation Proposed by Other States and the Fundamentals of
Proposition 37
In addition to federal regulation, state legislatures have also
"considered legislation focused on mandatory labeling of bioengineered"
foods; however, only a few states have passed laws requiring labeling of
bioengineered foods.88 For example, several states have enacted statutes
"relating specifically to genetically-modified fish species, reflecting the
large fish industries in those states." 89 Some states "have either mandatory
or voluntary labeling guidelines for both agricultural or food products,"
while twenty-two states "provide either funding, tax credits, or other
support for biotechnology development in their state."90 A large number of
bills have been proposed in state legislatures since 2002, "ranging in form
from economic incentives to prohibitions." 91 The rationale for state
legislation has varied. Hawaii, for example, proposed a GM bill
concentrated on the public's right to know, while in West Virginia,
policymakers sought to ban bioengineered foods in public schools. 92
85 Id. (citing H.R. 5269, 109th Cong. (2006)).
61d at 536.
87 Id.
8 AMA, REPORT 2, supra note 5, at 6-7 ("Only Alaska has passed a law, requiring that
bioengineered salmon be labeled (bioengineered salmon are not currently marketed)."); see ALASKA
STAT. ANN. § 17.20.040(a)(12)(A), (2)(14) (West 2013).
89 Doug Farquhar & Liz Meyer, State Authority to Regulate Biotechnology Under the
Federal Coordinated Framework, 12 DRAKE J. AGRIc. L. 439, 458 (2007).
9o Id. at 459 & n. 164 (explaining that the mandatory guidelines on GM products imposed by
various states often relate to bioengineered fish species, while other labeling regimes, such as that of
Maine, "provid[e] voluntary guidelines for labeling foods that contain one percent or less genetically
engineered ingredients.").
91 Id at 459-60 (stating that approximately 350 bills relating to GM technology regulation
have been introduced in thirty-six separate states, nineteen of which have enacted the proposed laws).
9 Id. at 460.
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Despite some success at the state level, "as the public demand grows,"
many of these state actions will be subject to federal preemption by USDA,
EPA, or FDA regulations.93
A recent demand for mandatory labeling on GM products was
voiced in California, resulting in the "California Right to Know Genetically
Engineered Food Act," an initiated state statute also known as Prop 37.94
Prop 37 differed from previous attempts by state legislatures to pass
labeling laws due to its expansive scope and rigorous requirements. The
initiative would have taken effect in July 2014 and required labeling of GM
foods sold in retail stores, enforceable by the California Department of
Public Health.95 The proposed exemptions from labeling included: alcoholic
beverages; organic food derived entirely from animals like meat, eggs and
some dairy products; restaurant food; and specific raw foods produced
inadvertently through GE seed.96 If it had passed, Prop 37 would have
executed "a zero tolerance policy for accidental presence of small amounts
of GM substances, even if the U.S. government ha[d] approved the GM
material for human consumption." Specifically, the initiative would have
imposed extremely low tolerance levels for the "adventitious presence" of
GM ingredients from 2014 to 2019, and as of July 2019, the zero tolerance
policy would have been enforceable.
California's strict regulation proposal placed very high compliance
expectations on farmers and the food industry. Opponents claim such
extensive restrictions are not practical in the U.S. "due to the technicalities
of grain production, handling, processing, and storage," especially since
GM crops are increasingly prevalent.99 However, mandatory labeling
schemes employed abroad demonstrate that very low or zero tolerance GM
substance policies "fai[l] to result in consumer choice because stores have
chosen not to sell foods" with GM components to avoid the required
compliance with strict labeling requirements. 00 Instead, food manufacturers
are incentivized to use substitute ingredients like "imported palm oil to
replace soybean or canola oil," which are correlated with "potential health
problems."' 0 ' The strict policies behind Prop 37 would have likely resulted
in a similar situation in California.
9 Farquhar & Meyer, supra note 89, at 461.
9 See California Proposition 37, supra note 9.
9 See Carter et al., supra note 2, at 4.
96 id
9 Id at 3.
9 Id at 4.
SId. at 3.
10 AMA, REPORT 2, supra note 5, at 7.
'' Carter et al., supra note 2, at 4.
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B. Case Law and Potential Federal Preemptive Effect on State GM
Labeling Legislation
Prop 37 would have also prohibited utilizing terms such as
"natural," "naturally made," "naturally grown," and "all natural" in the
labeling and advertising of GM products and possibly even all foods.102
This provision was most likely formulated in response to California case
law regarding bioengineered food labeling. Consumers in lawsuits
involving mandatory labeling statutes raised arguments regarding their right
to know the contents of food products. For example, in Briseno v. ConAgra
Foods, Inc., a class action lawsuit was filed against ConAgra Foods, the
plaintiffs contended that ConAgra's labeling and advertising of certain
cooking oils as "100% Natural" was deceptive and likely to mislead the
public. 10 3 Briseno, on behalf of the class, claimed that contrary to
ConAgra's representations, the cooking oils were produced from "plants
grown from genetically modified organism seeds;" and thus, the products
were inherently unnatural.'" Specifically, the plaintiffs demanded an order
from the court requiring ConAgra to make "appropriate disclosure of
genetically modified ingredients and/or remov[e] . . . misleading natural
claims" in compliance with California law.os
In response, ConAgra claimed the FD&C Act preempted Briseno's
claims because the FDA "has repeatedly concluded that bioengineered
foods are not meaningfully different from foods developed by traditional
plant breeding, and thus that the fact that a food product is derived from
bioengineered plants need not be reflected on a product's label." 0 6
However, the District Court found federal preemption was only applicable
to one portion of Briseno's claim. The court held the plaintiff's request for
an order requiring ConAgra to adopt and enforce a policy requiring
disclosure of GM substances in its food products could not be granted,'0o
since the order "would impose a requirement that is not identical to federal
law." 08 However, the complaint primarily alleged that the use of the phrase
"100% Natural" was misleading, not that ConAgra should include
additional information in its cooking oil labels. 109
In similar cases, courts held marketing food products as "natural"
could be misleading, and the plaintiffs deceptive advertising accusations
may not suffer preemption since no conflict existed between FDA policy
102 id
103 Briseno v. Conagra Foods, Inc., No. CV 11-05379 MMM (AGRx), 2011 U.S. Dist.
LEXIS 154750, at *5 (C.D. Cal. Nov. 23, 2011).
"4 Id. at *4.
1o5 Id at *6.
'
0 Id. at * 13.
'o' Id. at *14 n.14.
"o Id. at *27.
'
09Briseno, 2011 U.S. Dist. LEXIS 154750, at *14 & n.14.
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and state law regarding the term "natural."110 Accordingly, the court in
Briseno held ConAgra failed to reference an applicable provision in either
the FD&C Act or in an FDA regulation involving the phrase "100%
Natural" or stipulating "a product cannot be labeled 'natural' despite being
produced from genetically modified plants."' 11 The FDA has declined to
establish a definition for the word "natural," despite strong consumer and
industry interest regarding the term's "confusing and misleading" nature.112
Alternatively, ConAgra relied on an FDA guidance report discussing
bioengineered foods and asserted the agency had made no distinction
between natural oils and those made from bioengineered plants. 113 The
court, however, interpreted the FDA report in exactly the opposite manner,
stating:
If anything, the guidance reinforces the view that a food
producer's statement as to whether a product contains
genetically modified ingredients can be misleading, and
supports Briseno's assertion that there is a distinction
between affirmatively representing that a product is 100%
Natural and omitting the fact that the product contains
bioengineered foods from its label . . . As a result the
document does not support ConAgra's assertion that the
FDA has concluded that there is no distinction between
natural and bioengineered foods, or that statements
concerning genetic modification, or the lack thereof, cannot
be misleading.1 14
Furthermore, the court clarified that even if the FDA report
buttressed ConAgra's argument, no preemption could occur because the
guidance report does not possess "the force of federal law," as "it is merely
a non-binding draft distributed for comment purposes."' 15 Briseno is an
important case because it establishes the boundaries of federal preemption
from the FD&C Act and FDA regulation. At a minimum, California courts
determined manufacturers might not be compelled to adopt and enforce
110 Id at *15 (quoting Wright v. General Mills, Inc., No. 08CV1532 L(NLS), 2009 U.S. Dist.
LEXIS 90576, at *2-3 (S.D. Cal. Sept. 30, 2009)); see also Farquhar & Meyer, supra note 89, at 468
("[C]ourts require either explicit preemption or conflict preemption in order to preempt a state or local
regulation. No state may completely exclude federally licensed commerce.. .but it may put limits on that
commerce unless preempted by federal legislation. If both regulations may be enforced without
impairing the federal regulation, and it is possible to comply with both regulations, then the state
regulation may stand.").
.. Briseno, 2011 U.S. Dist. LEXIS 154750, at *20.
11 Id at *16.
... Id at *20-2 1.
H4 Id. at *21-22.
us Id. at *22.
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policies requiring disclosure of genetically modified ingredients and federal
law preempts such a court order."' 6 However, states have avoided this
restriction, "by setting up standards for voluntary labeling," which "give
both producers and consumers a uniform guide for the use of certain
terms."" 7 A plaintiff may potentially argue a food company's label is
misleading if it is branded as "Natural" or "100% Natural," when the
product contains GMOs; to succeed, the plaintiff must plead such a claim
with particularity of "when, where, and how the alleged misrepresentations
were communicated" to him or her." 8
Other jurisdictions have provided different justifications for
dismissing plaintiffs' claims or granting injunctions against statutes
designed to enforce labeling of certain GM food products. In International
Dairy Foods Ass'n v. Amestoy, the Second Circuit granted a preliminary
injunction on the basis of a violation of free commercial speech against
enforcement of a Vermont statute requiring labeling of certain dairy
products produced through the use of a synthetic growth hormone."' In
1993, the FDA approved for use the hormone at issue in Amestoy,
recombinant Bovine Somatotropin ("rBST"), because it was "undisputed
the dairy products derived from herds treated with rBST" were
"indistinguishable from products derived from untreated herds;" the
difference was that treated herds experienced increased milk production. 2 0
The statute presented various labeling options for rBST-enhanced dairy
products, and, in response, dairy manufacturers and others filed suit,
alleging the statute was unconstitutional because it infringed on guaranteed
First Amendment rights.121 Vermont did not claim any "health or safety
concerns" as justifications for promoting the labeling law" 22 because there
was no scientific basis for such an assertion. The FDA had already
conducted exhaustive studies on the effects of the rBST hormone and
concluded there was no risk to human health from consumption.123
Thus, the Amestoy court agreed with the dairy manufacturers,
holding that strong public interest in the consumer's right to know is an
inadequate justification for "compromising protected constitutional
1' Farquhar & Meyer, supra note 89, at 469 ("Congress has expressed a desire to preempt
state labeling requirements through the National Uniform Nutritional Labeling clause of the FDCA ...
state regulations of food labels must be identical to FDA regulations. . . .").
"' Id. at 471 ("Other states have chosen to incorporate the use of genetically-modified
ingredients into their definitions of'organic,' requiring that organic products be produced with minimal
or no biotechnology.").
"' Briseno, 2011 U.S. Dist. LEXIS 154750, at *37-38 (holding that plaintiff failed to plead
his claim with particularity as required by Rule 9(b) of the Federal Rules of Civil Procedure).
"' Int'l Dairy Foods Ass'n v. Amestoy, 92 F.3d 67, 69 (2d Cir. 1996) (distinguished by New
York State Restaurant Association v. New York City Board of Health, 556 F.3d 114 (2d Cir. 2009)).
120 id
121 Id. at 69-70.
122 Id at 73.
123id
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rights."l24 The court acknowledged the state's interest in educating its
public, but found such interest is, "insufficient to permit . . . Vermont to
compel the dairy manufacturers to speak against their will."1 25 Unless the
material requested by consumers "bears on a reasonable concern for human
health or safety or some other sufficiently substantial governmental
concern," manufacturers cannot be forced to disclose such information.126
The rBST hormone is one such example of a bioengineered gene where no
concern for health and safety exists through its use, yet many consumers
want an informational label.
Case law in California and Vermont may be an indication of
potential legal responses if legislation similar to Prop 37 is eventually
passed, in light of current FDA regulatory policies. Federal preemption will
likely occur if plaintiffs petition the court for mandatory labeling on GM
products based solely on public interest, rather than on concerns involving
risks to consumer health and safety.12 7 Furthermore, complaints based on
misleading statements on labels will likely suffer dismissal, especially in
class action disputes, if the plaintiffs cannot provide specific information
about when and how the alleged misrepresentations were communicated.
The case law discussed above reflects the consumer right to know
argument, which courts have repeatedly found unconvincing.
The AMA agrees with the reasoning behind these decisions, stating
"consumer curiosity alone is not enough to require special labeling."' 2 8
Mandatory labeling "may mislead consumers into thinking that
bioengineered foods are less safe than their conventional counterparts" and,
"it places a burden on the FDA itself, which would have to . . . address
consumer curiosity," instead of focusing on more important, safety-based
labeling measures.12 9 Furthermore, as mentioned in Amestoy as a potential
concern, introducing special labeling could create the opportunity for
unreasonable, informational consumer requests for manufacturer
disclosure.130 In addition to the potential liability manufacturers and the
food industry already face, Prop 37 would have exposed these actors to
even more consumer-based litigation. 131 Specifically, in a Prop 37-based
claim, consumers could potentially recover damages equal to or greater
124 id
125 Amestoy, 92 F.3d at 74.
127 Farquhar & Meyer, supra note 89, at 469-70 ("Because the FDA has determined that
information about biotechnology used in the production of food is not necessary nutritional or safety
information, it is unlikely it will find the general public of a state has a particular need for information;
and thus, it is unlikely that the FDA will grant an exemption for mandatory labeling.").
128 AMA, REPORT 2, supra note 5, at 7.
129 id
130 Id.; see also Amestoy, 92 F.3d at 74 ("Were consumer interest alone sufficient, there is no
end to the information that states could require manufacturers to disclose about their production
methods.").
131 See Carter et al., supra note 2, at 4.
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than the retail price of each package or product alleged to be in violation of
the proposed statute.13 2 Moreover, consumers would not even need to prove
specific damages from the alleged violation to successfully sue under the
proposed initiative. 133
According to the Giannini Foundation of Agricultural Economics,
"mandatory labeling is unnecessary because voluntary labeling now gives
California consumers a choice to purchase food products that do not contain
GMOs."l 34 Consumers have the option to purchasing USDA organic food
products if they wish to avoid substantial GMO consumption. However,
unlike the zero tolerance policy in Prop 37, "the USDA has not established
a threshold level for adventitious presence of GM material in organic
foods."' 35 Therefore, organic farmers strongly supported the California
initiative for two reasons. First, its passage would have greatly expanded
their market share to the detriment of consumers "since the per-unit cost of
producing non-GM crops is less than organic crops."l 36 Second, if Prop 37
had passed, it would have exempted organic products from mandatory
labeling requirements entirely. Thus, as agricultural economists suggest, "a
food product could be labeled as organic and escape the testing and
litigation issues facing a similar non-organic product even if both products
contained identical accidental trace amount of GM material."l3 7
Additionally, certain products sold by Whole Foods and Trader Joe's "are
formulated to avoid GE Ingredients," although they may not be organic. 3 8
Shopping at one of these retailers provides consumers another
option to avoid buying GM products. Some of their items are marketed as
"GM-free products," voluntarily labeled through the "Non-GMO Project," a
verification procedure controlled by store retailers utilizing a 0.9%
threshold for trace GM substance.13 9 For example, Whole Foods receives a
premium for selling various GM-free products; furthermore, all food items
sold under Trader Joe's label are produced from non-GM ingredients, but
Trader Joe's is not a participant in the Non-GMO Project.14 0 However,
unlike organic farmers, food retailers such as Whole Foods and Trader
Joe's did not avidly support Prop 37, despite their apparent commitment to
selling GM-free food.14 1 Such retailers likely withheld their support
because, as in the case of Trader Joe's, certain processed food products or
132id
133 id
134 Id at 5.
135 id'.
136 Id. at 4 (explaining that consumers will have been disadvantaged since "overall food
prices" would have risen "as non-GM food products" were replaced).
In Id. at 5.
138id.
13 id.
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those not privately labeled "would likely require the new cautionary label
under Prop 37," along with "all of the products under the Trader Joe's line
that w[ould] not meet the zero tolerance."l 42 If Prop 37 had passed,
agricultural economists predicted a large number of conventionally
produced foods would have disappeared from the shelves. 14 3 Instead, stores
would have been stocked with either organic products or properly labeled
GM products.1" The initiative included a labeling exception for highly
processed foods, but employing the non-labeled option may have only been
sensible "using either lower grade or more expensive alternative
ingredients." 145
Ultimately, Prop 37 would not have affected organically certified
products, animal products, alcoholic beverages, restaurant food, or fruits
and vegetables. The food sources that would have sustained the most
significant impact account for the majority of foodstuffs found in grocery
stores. Processed foods containing soy and corn ingredients and non-GM
labeled foods with trace amounts of GM substances above the threshold
would have either had to be properly labeled, produced with alternative
ingredients, or converted to certified organic; otherwise, food
manufacturers, suppliers and retailers would be risking the possibility of
costly litigation. 14 6 The California initiative would have negatively
impacted the food industry by increasing consumer prices, introducing
confusing labels, and eliminating less expensive, perfectly safe food items.
However, if Prop 37 had survived the vote, it is very likely the state action
would have been preempted under certain FDA regulation. Labeling
activists supporting the "Right to Know" food movement undoubtedly have
legitimate, personal reasons for doing so, but the concern is largely
unfounded, and the imposition of a strict labeling regime would ultimately
result in a significant burden on consumers.
V. THE FUTURE OF THE GM FOOD MOVEMENT IN AMERICA:
ALTERNATIVES TO MANDATORY LABELING
Labeling proponents vowed to expand the "Right to Know" food
movement despite Prop 37's defeat in California. In a statement released
after Prop 37 failed, a "Right to Know Campaign" spokesperson declared,
"'we showed that there is a food movement in the United States, and it is
strong, vibrant and too powerful to be stopped."'l 4 7 A similar initiative is
142 id
143 Id. at 4.
'" Id.
145 id
'" Id at 7.
147 Victoria Cavaliere, California Voters Reject Measure Labeling Genetically Engineered
Food; Supporters Vow to Fight On, N.Y. DAILY NEWS (Nov. 7, 2012, 4:01 PM),
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already gathering momentum in Washington. Named "The People's Right
to Know Genetically Engineered Food," the proposed Act seeks to establish
mandatory labeling for GM food products.14 8 The Washington initiative
will likely imitate the rigorous labeling policies presented in Prop 37. Pro-
labelers emphasize the California initiative was only defeated by a narrow
margin of about 52% to 47%, indicating massive support for the Right to
Know campaign.149 Those supporting Prop 37 further argue that a media
blitz, funded by the food industry and strategically timed several weeks
before the vote, explains the initiative's failure. Pro-labelers maintain the
food industry is worried the American public will be alarmed after discover
the contents of its food products, and, thus it is willing to spend millions to
impede the labeling movement.150 Following the failure of Prop 37, the
future of the labeling crusade is unclear, but as the "Right to Know"
movement permeates Washington, the food industry and concerned
consumers brace for another battle in the war on GM food.
Even though labeling activists pledge to continue fighting, more
than the passage of a vote stands in the way of their ultimate goal. The food
movement in the United States faces a significant challenge due to "deeply
rooted" federal regulatory policies and "various constitutionally volatile and
statutorily preemptive hurdles facing legislatively compelled labeling."s15
Alliance demonstrates that, "courts will show extreme deference to the
FDA's judgment and . . . GM-food critics have little legal ground upon
which to stand when attempting to compel GM-food labeling."l 52 This case
and others established the current precedent that "a consumer's limited right
to know is insufficient" to demand mandatory labeling from the FDA."'
Therefore, even if initiatives similar to Prop 37 eventually succeed, these
"legislative attempts at mandatory GM food labeling" will likely face
immediate appeal in the courts and will most likely be invalidated.15 4
From the perspective of a neutral bystander, arguments
underpinning the consumer's right to know philosophy are compelling.
Eating food is a personal, basic human function, and claiming a right to
know the ingredients of one's meal seems reasonable. Upon closer analysis,
http://www.nydailynews.comlife-style/health/california-voters-reject-food-labeling-measure-article-
1.1198269.
14 1-522: The People's Right to Know Genetically Engineered Act, COMMON GROUND,
http://commonground.ca/2013/04/label-gmo-foods/ (last visited Aug. 20, 2013).
'4 California Right to Know Campaign, Prop 37: Vote Count and Results, YES ON 37 RIGHT
TO KNow BLOG (Nov. 10, 2012, 4:12 PM), http://www.carighttoknow.org/l 51504/votecount.
1so Cass R. Sunstein, Don't Mandate Labeling for Gene-Altered Foods, BLOOMBERG (May
12, 2013, 6:00 PM), http://www.bloomberg.connews/2013-05-12/don-t-mandate-labeling-for-gene-
altered-foods.html; see also Jacob Chamberlain, Industry Giants Mobilizing to Kill Growing GMO
Movement, COMMON DREAMS (July 3, 2013), https://www.commondreams.org/headline/2013/07/03-9.
' See Galant, supra note 1, at 128.
1521d. at 152.
l$4 Id at 159.
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however, it is apparent "mandatory GM food labeling is not a viable
option."' 55 Using agricultural biotechnology in the United States is too
important and its benefits are too numerous to ignore. Despite years of
scientific study and research indicating the safety of GMOs for human
consumption, "emotionally charged consumers deman[d]" a mandatory
labeling scheme. A compromise must be met to quell the labeling
conflict; otherwise, the labeling crusade will gamer strength, potentially
resulting in destructive changes in federal regulation. The question still
remains, can major players in the food industry realistically continue to
spend millions in an effort to halt the labeling movement?
The potential unknown risks associated with GM food products
most directly inflame consumer fear surrounding agricultural
biotechnology. As a result, "negative public sentiment" correlates with a
"general lack of knowledge" about transgenic methods, but "even when
consumers do receive information about GM foods, they are vulnerable to
the high impact marketing of public interest groups and 'media
sensationalization.' '15 Therefore, a possible solution involves exploring
"existing protections and alternatives and helping" consumers "understand
the limitations that mandatory GM-food labeling faces." 5 In its recent
recommendation, the AMA "supports efforts for the mandatory pre-market
systematic safety assessments" of GM foods; currently, the FDA permits
voluntary pre-market notification processes, and all manufacturers who
want to market new bioengineered products have resolutely followed this
practice. 159Nevertheless, consumer fears may be eased if the FDA modified
its policy and required a mandatory notification process. Moreover, the
AMA "urges government, industry, consumer advocacy groups, and the
scientific and medical communities to . . . improve the availability of
unbiased information and research activities on bioengineered foods."l 60
Survey evidence indicates roughly 70-75% of consumers would be more
likely "to purchase GM foods if they were notified that the modifications
were for the purposes of providing healthful fats . . . requiring less
pesticide, reducing content of saturated and trans fats, or producing better-
tasting or fresher foods."' 6 ' Therefore, if, as the AMA suggests, unbiased,
science-based information is disseminated to the American public,
significant strides can be made to inform consumers without the institution
of mandatory labeling.
"' Id. at 164.
116 Id. at 128.
sId. at 129-30.
Id. at 128.
1" AMA, REPORT 2, supra note 5, at 8.
I6o Id at 9.
161 Federici, supra note 7, at 534.
200
CALIFORNIA'S PROPOSITION 37
Alternatively, opponents of agricultural biotechnology argue
labeling may be the most effective avenue to educate the public "about the
large array of genetic modifications and altered attributes of GMOs so they
may make informed choices and may avoid GMOs if they wish."' 6 2 Further,
"[a]s consumers acquire more information and more familiarity with GM
foods, they are likely to become more comfortable" and more supportive of
the technology, while "[a]t the same time . . . producers would still be
permitted to grow GMOs."l 63 However, if a labeling regime were
implemented in the United States, it would be most effective if it permitted
a higher, more practical threshold for trace levels of GMO substances in
food products. As an alternative, the United States could adopt a more
practical approach, allowing for more flexible thresholds "to cope with the
practicalities of low levels of unintended" of GM substances.164 For
example, in Japan, "the legal labeling tolerance level for accidental
presence of GM ingredients in non-GM food is 5% of the top three
ingredients."s6 5 This margin of error enables consumers to purchase non-
GM food rather than be forced to purchase organic products; Prop 37 would
have basically eliminated this option for California consumers.166
Conversely, the probable costs imposed on the public through enacting a
zero tolerance GM policy would significantly outweigh the benefits of
labeling.
VI. CONCLUSION
Although many individuals consider what they choose to eat an
extremely important and personal decision, mandatory labeling of GM food
products is an unnecessary and burdensome resolution to secure a
consumer's right to know the ingredients in his or her diet. Various
alternatives to labeling exist in which a compromise between consumers
and the food industry can be formed, ensuring public confidence in the
safety of agricultural technology while maintaining scientific progress in
this field. State action in the form of regulatory measures like Prop 37 may
continue, but under current federal regulation, preemption is likely to occur
if the proposals extend beyond permissible limits enforced by agencies such
as the FDA, USDA, and EPA. However, consumers should be reassured
because these "regulatory agencies administer their policies using the most
current and sound scientific data available," 67 and until there is a scientific
justification for mandatory labeling based on proven health risks, voluntary
162 Id. at 532.
163 Id. at 532-33.
'64 See Carter et al., supra note 2, at 3.
165 id
'
66 Id. at 5.
167 See Galant, supra note 1, at 159.
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labeling with FDA guidance is the most practical option to strike a balance
between food consumer and food supplier rights.
